Whipplewood Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.78K Sell
74
-164
-69% -$14.3K ﹤0.01% 283
2026
Q1
$20.3K Buy
+238
New +$21.2K 0.01% 394
2025
Q3
Sell
-531
Closed -$48.3K 465
2025
Q2
$48.3K Sell
531
-191
-26% -$17.4K 0.03% 321
2025
Q1
$68.2K Sell
722
-1
-0.1% -$90 0.04% 264
2024
Q4
$65.7K Buy
+723
New +$69K 0.04% 273

Other funds holding CL

Whipplewood Advisors's CL Position: Q2 2026 in Review

Whipplewood Advisors reduced its Colgate-Palmolive (CL) stake by 69% in Q2 2026, selling an estimated $14.3K and leaving 74 shares worth $6.78K. The position accounts for ﹤0.01% of the portfolio, ranked #283.

Whipplewood Advisors first reported a position in CL in Q4 2024 and has held it in 5 quarters since. The position peaked at $68.2K in Q1 2025. 674 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Whipplewood Advisors held 74 shares of Colgate-Palmolive worth $6.78K as of Q2 2026.
  • Whipplewood Advisors sold 164 Colgate-Palmolive shares in Q2 2026, an estimated $14.3K.
  • Colgate-Palmolive made up ﹤0.01% of Whipplewood Advisors's portfolio in Q2 2026, its #283 holding.
  • Whipplewood Advisors first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 5 quarters since.
  • Whipplewood Advisors's Colgate-Palmolive position peaked at $68.2K in Q1 2025.
  • 674 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.